Skip to main content
. 2018 Jan 24;9(1):62–71. doi: 10.1055/s-0037-1617451

Table 3. Overdue screening and surveillance among routine/normal and abnormal end points.

End point type Total patients
(T)
Total patients with definite time for next follow-up (P) Total patients overdue (O) Percentage
patients overdue (O/P)
Routine/normal 307 200 46 23.0%
Abnormal 86 81 54 66.7%